Venture Associates Ii Llc Lux files SEC Form 4 disclosures for Cerulean Pharma Inc.. They have made 1 open-market trade across 1 company since 2014, most recently 2014-04-15.
CIK 0001592842
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $744K since 2014, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CERU | 951,999 | $6.2M |
Shares reported on the most recent Form 4, priced at the 2014-04-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CERU | BUY | 2014-04-15 | 2014-04-15 | $7.00 | $744K | -13.3% | +3.4% | +3.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.